OliX Pharmaceuticals Inc.

In News

OliX Pharmaceuticals Secures KRW 110 Billion Investment from BOLD, L’Oréal Corporate Venture Capital Fund, and Weiss, U.S. Hedge Fund - Business Wire

Business Wire - Jun 04, 2026

OliX Pharma Raises $80M for siRNA Pipeline - AllSci

AllSci - Jun 04, 2026

Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals - GlobeNewswire

GlobeNewswire - Feb 03, 2026

OliX’s OLX501A Demonstrates Greater Visceral Fat Reduction Relative to a Global Comparator in Obese Non-Human Primates - Business Wire

Business Wire - Jul 30, 2026

OliX Pharmaceuticals secures KRW 110 billion investment from L’Oréal venture fund and Weiss Asset Management - Global Cosmetics News

Global Cosmetics News - Jun 05, 2026

OliX licenses two siRNA candidates to China’s Hansoh, keeps rest for Korea deals - CHOSUNBIZ - Chosunbiz

Chosunbiz - Aug 21, 2026

L'Oréal Bets $72.5 Million on Olix's Hair Loss and Obesity siRNA Technology - finance.biggo.com

finance.biggo.com - Jun 01, 2026

OliX Unveils Dual-Target RNAi Platform at Shanghai Conference - Seoul Economic Daily

Seoul Economic Daily - Sep 10, 2026

OliX Pharmaceuticals Announces Positive Results from a Phase 2a Trial of OLX10010 for Hypertrophic Scar Treatment - BioSpace

BioSpace - Apr 28, 2023

OliX strikes $630 million deal with Lilly for obesity and liver disease drug - Korea Biomedical Review

Korea Biomedical Review - Feb 10, 2025

OliX Confirms Visceral Fat Reduction in Obesity Drug Preclinical Study - Seoul Economic Daily

Seoul Economic Daily - Jul 30, 2026

OliX and Lilly Enter Global Licensing Agreement for MASH and Other Cardiometabolic Indications - Business Wire

Business Wire - Feb 10, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment